Green Planet Bio Engineering Co., Ltd. Files 2023 Annual Report on Form 10-K

TL;DR

<b>Green Planet Bio Engineering Co., Ltd. has filed its 2023 annual report on Form 10-K, detailing its financial and operational status.</b>

AI Summary

Green Planet Bio Engineering Co. Ltd. (GPLB) filed a Annual Report (10-K) with the SEC on March 29, 2024. Green Planet Bio Engineering Co., Ltd. filed its annual report on Form 10-K for the fiscal year ended December 31, 2023. The company is incorporated in Delaware and its principal executive offices are located in Aventura, Florida. The company's IRS Employer Identification Number is 37-1532842. The filing indicates that no securities are registered pursuant to Section 12(b) or 12(g) of the Act. The company is not a well-known seasoned issuer.

Why It Matters

For investors and stakeholders tracking Green Planet Bio Engineering Co. Ltd., this filing contains several important signals. This 10-K filing provides a comprehensive overview of Green Planet Bio Engineering's financial performance and business operations for the fiscal year 2023, which is crucial for investors to assess the company's health and future prospects. The absence of registered securities under Section 12(b) or 12(g) and its status as not a well-known seasoned issuer may indicate a smaller or less publicly traded entity, impacting liquidity and investor accessibility.

Risk Assessment

Risk Level: low — Green Planet Bio Engineering Co. Ltd. shows low risk based on this filing. The risk is low as this filing is a standard annual report (10-K) and does not contain immediate negative financial disclosures or significant operational changes. The provided text is purely informational about the filing itself.

Analyst Insight

Investors should review the full 10-K filing for detailed financial statements, risk factors, and management's discussion and analysis to form an informed opinion on Green Planet Bio Engineering Co., Ltd.

Key Numbers

• 2023-12-31 — Fiscal Year End (The report covers the fiscal year ending on this date.)
• 2024-03-29 — Filing Date (The date the 10-K report was filed.)
• 37-1532842 — IRS EIN (Employer Identification Number.)
• 000-52622 — SEC File Number (The SEC's file number for the company.)

Key Players & Entities

• Green Planet Bio Engineering Co., Ltd. (company) — Filer of the 10-K report.
• 20807 Biscayne Blvd., Suite 203, Aventura, Florida 33180 (location) — Principal executive offices address.
• 37-1532842 (organization_id) — IRS Employer Identification Number.
• December 31, 2023 (date) — Fiscal year end date.
• 20240329 (date) — Filing date.
• 000-52622 (registration_id) — Commission file number.

FAQ

Key Dates

• 2023-12-31: Fiscal Year End — Marks the end of the reporting period for the 10-K.
• 2024-03-29: 10-K Filing Date — The date the annual report was officially submitted to the SEC.

Glossary

10-K

An annual report required by the U.S. Securities and Exchange Commission (SEC), which gives a comprehensive summary of a company's financial performance. (This is the primary document filed by Green Planet Bio Engineering Co., Ltd. to report its annual financial status.)

Fiscal Year End

The last day of a company's accounting year. (Indicates the period covered by the financial statements in the 10-K filing.)

Key Financial Figures

• $5.00 — ty that has a market price of less than $5.00 per share. Our common stock, when and i
• $47,670 — s ended December 31, 2023 and 2022 were $47,670 and $32,533, respectively. The majority
• $32,533 — mber 31, 2023 and 2022 were $47,670 and $32,533, respectively. The majority of these ex

Filing Documents

• gplb_10k.htm (10-K) — 328KB
• gplb_ex311.htm (EX-31.1) — 10KB
• gplb_ex312.htm (EX-31.2) — 12KB
• gplb_ex32.htm (EX-32) — 4KB
• gplb_10kimg7.jpg (GRAPHIC) — 7KB
• 0001654954-24-003942.txt (&nbsp;) — 1419KB
• gplb-20231231.xsd (EX-101.SCH) — 15KB
• gplb-20231231_lab.xml (EX-101.LAB) — 94KB
• gplb-20231231_cal.xml (EX-101.CAL) — 17KB
• gplb-20231231_pre.xml (EX-101.PRE) — 68KB
• gplb-20231231_def.xml (EX-101.DEF) — 13KB
• gplb_10k_htm.xml (XML) — 106KB

Business

Business 4 Item 1A.

Risk Factors

Risk Factors 4 Item 1B. Unresolved Staff Comments 5 Item 2.

Properties

Properties 5 Item 3.

Legal Proceedings

Legal Proceedings 5 Item 4. Mine Safety Disclosures 5 PART II Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 6 Item 6.

Selected Financial Data

Selected Financial Data 6 Item 7.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 6 Item 7A.

Quantitative and Qualitative Disclosures about Market Risk

Quantitative and Qualitative Disclosures about Market Risk 7 Item 8.

Financial Statements

Financial Statements 8 Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 17 Item 9A.

Controls and Procedures

Controls and Procedures 17 Item 9B. Other Information 17 PART III Item 10. Directors, Executive Officers and Corporate Governance 18 Item 11.

Executive Compensation

Executive Compensation 19 Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 19 Item 13. Certain Relationships and Related Transactions, and Director Independence 19 Item 14. Principal Accounting Fees and Services 19 PART IV Item 15. Exhibits and Financial Statement Schedules 20

Signatures

Signatures 21 2 Table of Contents

FORWARD-LOOKING STATEMENTS

FORWARD-LOOKING STATEMENTS This Annual Report on Form 10-K contains forward-looking statements. These statements involve risks and uncertainties, including, among other things, statements regarding our business strategy, future revenues and anticipated costs and expenses. Such forward-looking statements include, among others, those statements including the words "expects," "anticipates," "intends," "believes," "may," "will," "should," "could," "plans," "estimates," and similar language or negative of such terms. Our actual results may differ significantly from those projected in the forward-looking statements. Factors that might cause or contribute to such differences include, but are not limited to, those discussed in Item 7 "Management's Discussion and Analysis of Financial Condition and Results of Operations." You are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date of this report. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we do not know whether we can achieve positive future results, levels of activity, performance, or goals. Actual events or results may differ materially. We undertake no obligation to publicly release any revisions to the forward-looking statements or reflect events or circumstances taking place after the date of this document. 3 Table of Contents PART I

BUSINESS

ITEM 1. BUSINESS Description of Business Green Planet Bioengineering Co., Ltd. ("Green Planet" or "Company") operates as a public reorganized shell corporation with the purpose to acquire or merge with an existing business operation. Our History Mondo Acquisition II, Inc. was incorporated in the State of Delaware on October 30, 2006 and changed the name to Green Planet Bioengineering Co., Ltd. on October 2, 2008. In October 2008, the Company acquired Elevated Throne Overseas Ltd, a company incorporated in British Virgin Islands, and its subsidiaries ("Elevated Throne") which operated the business in the agritech sector in the People's Republic of China. The Company divested Elevated Throne to One Bio, Corp. ("ONE") on April 14, 2010. In March 2012, Global Funds Holdings Corp. ("Global Funds") an Ontario, Canada corporation became a majority stockholder of the Company. The Company operates as a public organized shell corporation with the purpose to acquire or merge with an existing business operation. The Company's activities are subject to significant risks and uncertainties, as their ability to implement and execute future business plans and generate sufficient business revenue is directly influenced by their ability to secure adequate financing or find profitable business opportunities.

RISK FACTORS

ITEM 1A. RISK FACTORS You should consider carefully each of the following business and investment risk factors and all of the other information in this report. If any of the following risks and uncertainties develops into actual events, the business, financial condition or results of our operations could be materially and adversely affected. If that happens, the trading price of our shares of common stock could decline significantly. The risk factors below contain forward-looking statements regarding our business. Actual results could differ materially from those set forth in the forward-looking statements. See "Special Note Regarding Forward-Looking Information." Risk Related to the Company's Future Business We give no assurances that any plans for future business will be implemented if we do not secure adequate financing or find profitable business opportunities. Our ability to implement and execute our future business plans and ultimately generate enough business revenue is directly influenced by our ability to secure adequate financing or find profitable business opportunities. If we do not receive funding from future investors or find profitable business opportunities, we will experience delays in our business plans and, ultimately, in our profitability going forward. We will continue to incur significant costs as a result of remaining as a public reorganized company, and management will be required to devote substantial time to new compliance requirements. As a public company, we incur significant legal, accounting and other expenses under the Sarbanes-Oxley Act of 2002, together with rules implemented by the Securities and Exchange Commission and applicable market regulators. These rules impose various requirements on public companies, including requiring certain corporate governance practices. Management and other personnel will need to devote a substantial amount of time to these new compliance requirements. Moreover, these rules and regulations

UNRESOLVED STAFF COMMENTS

ITEM 1B. UNRESOLVED STAFF COMMENTS None

PROPERTIES

ITEM 2. PROPERTIES None

LEGAL PROCEEDINGS

ITEM 3. LEGAL PROCEEDINGS None

MINE SAFETY DISCLOSURES

ITEM 4. MINE SAFETY DISCLOSURES None 5 Table of Contents PART II

MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES The Company's common stock is available for quotation on the Over the Counter Bulletin Board under the symbol "GPLB.PK." There is no assurance that the company's stock will continue to be quoted or that any liquidity will exist for our stockholders. The following table shows, for each quarter of fiscal 2023 and 2022 the high and low closing price per share of common stock as reported on the Over the Counter Bulletin Board. The following quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission, and may not represent actual transactions. The source of this information is NASDAQ Over the Counter Bulletin Board Research Report. 2023 2022 Quarter Ended High Low High Low Fourth Quarter $ 1.000 $ 0.061 $ 2.450 $ 2.000 Third Quarter 1.100 0.172 2.600 0.680 Second Quarter 1.100 0.161 0.810 0.280 First Quarter 2.500 0.200 0.350 0.180 We have never declared or paid any cash dividends on our common stock.

SELECTED FINANCIAL DATA

ITEM 6. SELECTED FINANCIAL DATA Not applicable.

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Overview The Company operates as a public reorganized corporation with the business purpose to acquire or merge with an existing business operation. Results of Operations The Company did not have any operations and did not have any operating revenues during the years ended December 31, 2023 and 2022, respectively. Total expenses for the years ended December 31, 2023 and 2022 were $47,670 and $32,533, respectively. The majority of these expenses primarily constituted administrative expenses related to accounting and compliance with the Exchange Act. Liquidity and Capital Resources The Company had no active business operation during the year. Accordingly, all the Company's cash flow needs for 2023 were provided solely by a related party of Global Funds to pay expenses necessary as a public company. Going forward, the Company will continue to source adequate funding from future investors to execute business opportunities when they arise in the future. However, such funding and business opportunities will rely entirely on the prevailing circumstances when the funding or profitable business opportunities are identified. If such opportunities are not identified in the near term, the Company will experience delay in effecting its business plans. The financial statements have been prepared assuming that the Company will continue as a going concern. The Company is currently a public reorganized shell corporation and has no current business activity. The Company's ability to continue as a going concern is dependent on continued support from Global Funds, the majority stockholder. This gives rise to substantial doubt about the Company's ability to continue as a going concern. 6 Table of Contents Critical Accounting Policies and Estimates We prepare our financial statements in conformity with accounting principles generally accepted ("GAAP") in the United States o

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK None 7 Table of Contents

FINANCIAL STATEMENTS

ITEM 8. FINANCIAL STATEMENTS INDEX TO FINANCIAL STATEMENTS Report of Independent Registered Public Accounting Firms 9

Financial Statements

Financial Statements: Balance Sheets 10 11 12 13 Notes to the Financial Statements 14 8 Table of Contents REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors and Stockholders of Green Planet Bioengineering Co., Ltd. Opinion on the Financial Statements We have audited the accompanying balance sheets of Green Planet Bioengineering Co., Ltd. (the Company) as of December 31, 2023 and 2022, and the related statements of operations, stockholders' deficit, and cash flows for each of the years in the two-year period ended December 31, 2023, and the related notes (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for each of the years in the two-year period ended December 31, 2023, in conformity with accounting principles generally accepted in the United States of America. Explanatory Paragraph- Going Concern The accompanying financial statements have been prepared assuming the Company will continue as a going concern. As discussed in Note 3 to the financial statements, the Company currently a public reorganized shell corporation and has no current business activity with losses of $ 47,670 as of December 31, 2023. The Company's ability to continue as a going concern is dependent on continued support from a related party. These factors raise substantial doubt about the Company's ability to continue as a going concern. This gives rise to substantial doubt about the Company's ability to continue as a going concern for a period of twelve months after the issuance of these financial statements. Management's plans concerning these matters are also described in Note 3. The financial statements do not include any ad

View Full Filing

View this 10-K filing on SEC EDGAR